secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cigna Group (CI)
CIK:        0001739940
Form:       8-K
Filed at:   2026-07-30T10:16:02+00:00
Accession:  0001140361-26-030135
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cigna Q2 2026 revenue $71.7B (+7% YoY), adj EPS $7.78, raises FY outlook to at least $30.45
--------------------------------------------------------------------------------

- Q2 revenue $71.7B (+7% YoY); net income $1.7B ($6.29 EPS) vs $1.5B ($5.71) a year ago.
- Adjusted income from operations $2.1B ($7.78 per share) vs $1.9B ($7.20) in Q2 2025.
- 2026 outlook raised: adjusted EPS at least $30.45 (up $0.10); Cigna Healthcare adj income guidance raised to at least $4.55B.
- Cigna Healthcare adj income pre-tax $1.28B (+17% YoY); MCR 84.5% vs 83.2%; medical customers 18.4M (+2% from Dec 2025).
- Evernorth adj income pre-tax $1.66B (-2% YoY) on client renewals; pharmacy customers 118.2M (-4%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739940/000114036126030135/0001140361-26-030135-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739940/000114036126030135/ef20078875_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-030135

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer